Edge Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Edge Advisors's BMY Position: Q2 2018 in Review
Edge Advisors held its Bristol-Myers Squibb (BMY) position steady in Q2 2018 at 5,447 shares worth $301K. The position accounts for 0.03% of the portfolio, ranked #266.
Edge Advisors first reported a position in BMY in Q4 2016 and has held it in 7 quarters since. The position peaked at $438K in Q4 2016. 1,691 funds tracked by Wall St. Rank hold BMY as of Q2 2018.
- Edge Advisors held 5,447 shares of Bristol-Myers Squibb worth $301K as of Q2 2018.
- Edge Advisors left its Bristol-Myers Squibb share count unchanged in Q2 2018.
- Bristol-Myers Squibb made up 0.03% of Edge Advisors's portfolio in Q2 2018, its #266 holding.
- Edge Advisors first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 7 quarters since.
- Edge Advisors's Bristol-Myers Squibb position peaked at $438K in Q4 2016.
- 1,691 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.
Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.